Table 2.
Open in new tab

|$\overline{T_{\rm f}}$| and |$\overline{T_{\rm p}}$| of hTelo 21-CTA at different concentration of ligand 360B or BG4 antibody

[360B]100 nM500 nM1 μM1.5 μM2 μM
|$\overline{T_{\rm f}}$| (s)1350±110750±110300±35130±1570±10
|$\overline{T_{\rm p}}$| (s)300±30450±60350±501050±2501350±300
[BG4]20 nM100 nM200 nM
|$\overline{T_{\rm f}}$| (s)1050±130400±30150±15
|$\overline{T_{\rm p}}$| (s)300±701150±1501250±250
[360B]100 nM500 nM1 μM1.5 μM2 μM
|$\overline{T_{\rm f}}$| (s)1350±110750±110300±35130±1570±10
|$\overline{T_{\rm p}}$| (s)300±30450±60350±501050±2501350±300
[BG4]20 nM100 nM200 nM
|$\overline{T_{\rm f}}$| (s)1050±130400±30150±15
|$\overline{T_{\rm p}}$| (s)300±701150±1501250±250

Means ± estimation error are indicated.

Table 2.
Open in new tab

|$\overline{T_{\rm f}}$| and |$\overline{T_{\rm p}}$| of hTelo 21-CTA at different concentration of ligand 360B or BG4 antibody

[360B]100 nM500 nM1 μM1.5 μM2 μM
|$\overline{T_{\rm f}}$| (s)1350±110750±110300±35130±1570±10
|$\overline{T_{\rm p}}$| (s)300±30450±60350±501050±2501350±300
[BG4]20 nM100 nM200 nM
|$\overline{T_{\rm f}}$| (s)1050±130400±30150±15
|$\overline{T_{\rm p}}$| (s)300±701150±1501250±250
[360B]100 nM500 nM1 μM1.5 μM2 μM
|$\overline{T_{\rm f}}$| (s)1350±110750±110300±35130±1570±10
|$\overline{T_{\rm p}}$| (s)300±30450±60350±501050±2501350±300
[BG4]20 nM100 nM200 nM
|$\overline{T_{\rm f}}$| (s)1050±130400±30150±15
|$\overline{T_{\rm p}}$| (s)300±701150±1501250±250

Means ± estimation error are indicated.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close